Literature DB >> 26661631

Recruitment of a Population-Based Sample of Young Black Women with Breast Cancer through a State Cancer Registry.

Devon Bonner1, Deborah Cragun1, Monique Reynolds1, Susan T Vadaparampil1,2, Tuya Pal1,2.   

Abstract

Given that Black women remain underrepresented in clinical research studies, we sought to recruit a population-based sample of young Black women with breast cancer through a state cancer registry. Demographic and clinical information on all Black women diagnosed with invasive breast cancer at or below age 50 between 2009 and 2012 in Florida was obtained through the state cancer registry. Survivors were invited to participate in the study through state-mandated recruitment methods. Participant demographic and clinical characteristics were compared using Chi-squared tests for categorical variables and the two sample t-test for continuous variables to identify differences between: (i) consented participants versus all other eligible; and (ii) living versus deceased. Of the 1,647 young Black women with breast cancer, mean age at diagnosis was 42.5, with the majority having localized or regional disease, unmarried, privately insured, and employed. There were no significant differences in demographic and clinical variables between the 456 consented study participants versus the remaining 1,191 presumed eligible individuals. Compared to potential participants, women determined to be deceased prior to recruitment (n = 182) were significantly more likely to have distant disease and a triple-negative phenotype. They were also significantly more likely to be unemployed, and uninsured or have public insurance (i.e., Medicaid or Medicare). Our results demonstrate that recruitment of a population-based sample of breast cancer survivors through a state cancer registry is a feasible strategy in this underserved and underrepresented population. However, survival bias, which was observed due to the lag time between diagnosis and recruitment, is important to adjust for when generalizing findings to all young Black breast cancer patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  African-American women; breast cancer; cancer registry

Mesh:

Year:  2015        PMID: 26661631      PMCID: PMC4775403          DOI: 10.1111/tbj.12545

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  31 in total

1.  Development of a culturally tailored genetic counseling booklet about hereditary breast and ovarian cancer for Black women.

Authors:  Jennifer Permuth-Wey; Susan Vadaparampil; Alnecia Rumphs; Anita Yeomans Kinney; Tuya Pal
Journal:  Am J Med Genet A       Date:  2010-04       Impact factor: 2.802

2.  Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.

Authors:  Kathleen E Malone; Janet R Daling; David R Doody; Li Hsu; Leslie Bernstein; Ralph J Coates; Polly A Marchbanks; Michael S Simon; Jill A McDonald; Sandra A Norman; Brian L Strom; Ronald T Burkman; Giske Ursin; Dennis Deapen; Linda K Weiss; Suzanne Folger; Jennifer J Madeoy; Danielle M Friedrichsen; Nicola M Suter; Mariela C Humphrey; Robert Spirtas; Elaine A Ostrander
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

3.  Recruiting African American women to participate in hereditary breast cancer research.

Authors:  Chanita Hughes Halbert; Kiyona Brewster; Aliya Collier; Chachira Smith; Lisa Kessler; Benita Weathers; Jill E Stopfer; Susan Domchek; E Paul Wileyto
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

4.  Patient perspectives on research recruitment through cancer registries.

Authors:  Laura M Beskow; Robert S Sandler; Robert C Millikan; Morris Weinberger
Journal:  Cancer Causes Control       Date:  2005-12       Impact factor: 2.506

5.  Research recruitment through US central cancer registries: balancing privacy and scientific issues.

Authors:  Laura M Beskow; Robert S Sandler; Morris Weinberger
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

6.  Updating and refining a study brochure for a cancer registry-based study of BRCA mutations among young African American breast cancer patients: lessons learned.

Authors:  Susan T Vadaparampil; Tuya Pal
Journal:  J Community Genet       Date:  2010-05-23

7.  Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study.

Authors:  C Royal; A Baffoe-Bonnie; R Kittles; I Powell; J Bennett; G Hoke; C Pettaway; S Weinrich; S Vijayakumar; C Ahaghotu; T Mason; E Johnson; M Obeikwe; C Simpson; R Mejia; W Boykin; P Roberson; J Frost; L Faison-Smith; C Meegan; N Foster; P Furbert-Harris; J Carpten; J Bailey-Wilson; J Trent; K Berg; G Dunston; F Collins
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

8.  Using a population-based cancer registry for recruitment in a pilot cancer control study.

Authors:  P A Newcomb; R R Love; J L Phillips; B J Buckmaster
Journal:  Prev Med       Date:  1990-01       Impact factor: 4.018

9.  Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.

Authors:  Anne Marie McCarthy; Mirar Bristol; Tracey Fredricks; Lache Wilkins; Irene Roelfsema; Kaijun Liao; Judy A Shea; Peter Groeneveld; Susan M Domchek; Katrina Armstrong
Journal:  Cancer       Date:  2013-07-16       Impact factor: 6.860

10.  Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer.

Authors:  Marijana Lijovic; Susan R Davis; Pam Fradkin; Maria La China; Helen Farrugia; Rory Wolfe; Robin J Bell
Journal:  BMC Cancer       Date:  2008-05-02       Impact factor: 4.430

View more
  7 in total

1.  The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer.

Authors:  Claire C Conley; Dana Ketcher; Maija Reblin; Monica L Kasting; Deborah Cragun; Jongphil Kim; Kimlin Tam Ashing; Cheryl L Knott; Chanita Hughes-Halbert; Tuya Pal; Susan T Vadaparampil
Journal:  J Genet Couns       Date:  2020-01-07       Impact factor: 2.537

2.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

3.  Health-related quality of life in Black breast cancer survivors with and without triple-negative breast cancer (TNBC).

Authors:  Susan T Vadaparampil; Juliette Christie; Kristine A Donovan; Jongphil Kim; Bianca Augusto; Monica L Kasting; Cheryl L Holt; Kimlin Ashing; Chanita Hughes Halbert; Tuya Pal
Journal:  Breast Cancer Res Treat       Date:  2017-03-03       Impact factor: 4.872

4.  Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.

Authors:  Claire C Conley; Monica L Kasting; Bianca M Augusto; Jennifer D Garcia; Deborah Cragun; Brian D Gonzalez; Jongphil Kim; Kimlin Tam Ashing; Cheryl L Knott; Chanita Hughes-Halbert; Tuya Pal; Susan T Vadaparampil
Journal:  Ann Surg Oncol       Date:  2019-11-01       Impact factor: 5.344

5.  Psychosocial impact of BRCA testing in young Black breast cancer survivors.

Authors:  Brian D Gonzalez; Aasha I Hoogland; Monica L Kasting; Deborah Cragun; Jongphil Kim; Kimlin Ashing; Cheryl L Holt; Chanita Hughes Halbert; Tuya Pal; Susan T Vadaparampil
Journal:  Psychooncology       Date:  2018-10-09       Impact factor: 3.894

6.  Recruitment Issues in Emerging Adult Populations: Focus on Adult Congenital Heart Disease.

Authors:  Laura Hays; Jean McSweeney; Anita Mitchell; Christina Bricker; Angela Green; Reid D Landes
Journal:  Nurs Rep       Date:  2020-12-02

7.  Recruitment of young adult cancer survivors into a randomized controlled trial of an mHealth physical activity intervention.

Authors:  Carmina G Valle; Lindsey N Camp; Molly Diamond; Brooke T Nezami; Jessica Gokee LaRose; Bernardine M Pinto; Deborah F Tate
Journal:  Trials       Date:  2022-04-04       Impact factor: 2.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.